Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Clinical Services Laboratory, |
RCV000299879 | SCV000445468 | benign | Tumor susceptibility linked to germline BAP1 mutations | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000422693 | SCV000521676 | benign | not specified | 2016-04-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000299879 | SCV000563726 | benign | Tumor susceptibility linked to germline BAP1 mutations | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000566867 | SCV000664589 | benign | Hereditary cancer-predisposing syndrome | 2015-06-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color | RCV000566867 | SCV000682574 | benign | Hereditary cancer-predisposing syndrome | 2016-03-09 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000299879 | SCV001157040 | benign | Tumor susceptibility linked to germline BAP1 mutations | 2019-03-04 | criteria provided, single submitter | clinical testing |